Trastuzumab deruxtecan in HER2-mutant NSCLC: evidence from the largest real-world cohort to date
Read the article

Geneva University Hospitals (HUG)
Prof. Alfredo Addeo is a consultant medical oncologist and head of the Lung Cancer Center at Geneva University Hospitals (HUG) in Geneva, Switzerland, with an affiliation to the Translational Research Centre in Oncohaematology at the University of Geneva. His work in non-small cell lung cancer focuses on immune checkpoint inhibitors, predictive and prognostic biomarkers, and oncogenic drivers including EGFR, HER2, and PD-L1. He is an active member of ESMO, the European Thoracic Oncology Platform (ETOP), and the IASLC, and is a frequent speaker at major international oncology congresses.
Alfredo Addeo
Programme Roster